← Eichor
Condition: Heart Transplant Recipients Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Heart Transplant Recipients

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

HIIT in Pediatric Heart Transplant Recipients (MedBIKE™)
NA · 1 location(s) · University of Alberta · NCT05451979
Intestinal Microsporidiosis in French Heart Transplant Recipients (CARMIC)
Phase N/A · 1 location(s) · University Hospital, Clermont-Ferrand · NCT06986980
Randomized Trial of SGLT2i in Heart Transplant Recipients
Phase 4 · 6 location(s) · VA Office of Research and Development · NCT06625073
Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipien
Phase 2 · 3 location(s) · Baylor Research Institute · NCT03383419
Levothyroxine Supplementation for Heart Transplant Recipients
Phase 1 · 1 location(s) · University of California, San Francisco · NCT06428097
Non-invasive Detection of Acute Cell-mediated Graft Rejection in Pediatric Heart Transplant Recipients
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06795958
The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
Phase 2 · 1 location(s) · University of North Carolina, Chapel Hill · NCT06059664
Microvascular Cardiac Allograft Vasculopathy Trial
Phase N/A · 1 location(s) · German Heart Institute · NCT05826444
Belatacept in Heart Transplantation
Phase 2 · 6 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06478017
Vascular Complications After Kidney Transplantation
Phase N/A · 3 location(s) · University of Aarhus · NCT07531966
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant R
NA · 4 location(s) · University of Florida · NCT05732779
Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients
Phase 2 · 1 location(s) · University of Pennsylvania · NCT06066957
Cardiopulmonary Stress Testing (CPET) AlloSure Study
Phase N/A · 1 location(s) · Baylor Research Institute · NCT04656080
Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant
Phase 2/Phase 3 · 2 location(s) · Columbia University · NCT07079735
Respiratory Strength Training in Heart Transplant Recipients
NA · 1 location(s) · Vanderbilt University Medical Center · NCT06190171
HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
NA · 1 location(s) · University of Texas Southwestern Medical Center · NCT06659952
Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients
Phase 2 · 1 location(s) · University Medical Centre Ljubljana · NCT05432778
Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)
NA · 1 location(s) · University Hospital, Grenoble · NCT06341543
Precision Medicine in the Management of Heart Transplant Recipients
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06774794
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.